ClinicalTrials.Veeva

Menu

Effects of Red Wine on Cardiovascular Risk Factors in Humans

U

University Hospital, Linkoeping

Status and phase

Completed
Phase 2
Phase 1

Conditions

Healthy Subjects

Treatments

Dietary Supplement: red wine

Study type

Interventional

Funder types

Other

Identifiers

NCT00954434
M246-08

Details and patient eligibility

About

Fifty healthy human subjects are randomized to not to consume any alcohol at all or to drink 1 glass of red wine/day for women or 2 glasses for men for three months. Outcomes are changes in mood, blood lipids, insulin levels, markers of inflammation and effects on liver and body composition.

Enrollment

44 patients

Sex

All

Ages

25 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy subjects
  • 25 years of age and older

Exclusion criteria

  • alcoholic first degree relatives

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

44 participants in 2 patient groups

red wine
Experimental group
Description:
intervention: dietary supplement intake of red wine on a daily basis, 1 glass/day for women, 2 for men
Treatment:
Dietary Supplement: red wine
total abstention from alcohol
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems